BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19451063)

  • 1. Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays.
    Maciá I Garau M; Solé Monné J; Cambra Serés MJ; Monfà Binefa C; Peraire Llopis M
    Clin Transl Oncol; 2009 May; 11(5):302-11. PubMed ID: 19451063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of unplanned interruptions in radiotherapy treatment schedules.
    Lindberg RD; Jones K; Garner HH; Jose B; Spanos WJ; Bhatnagar D
    Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):811-5. PubMed ID: 3350733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A national audit of radiotherapy in head and neck cancer.
    James ND; Robertson G; Squire CJ; Forbes H; Jones K; Cottier B;
    Clin Oncol (R Coll Radiol); 2003 Apr; 15(2):41-6. PubMed ID: 12708709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of interruptions to fractionated radiotherapy treatments: Four and a half years of experience.
    de la Vega JM; Ríos B; Del Río JT; Guerrero R; Castillo I; Guirado D
    Phys Med; 2016 Dec; 32(12):1551-1558. PubMed ID: 27890566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of the Overall Radiotherapy Time on Clinical Outcome of Patients with Nasopharyngeal Carcinoma; A Retrospective Study.
    Stoker SD; Fles R; Herdini C; Rijntjes FJ; Tjokronagoro M; Dwidanarti SR; Sikorska K; Leemans CR; Schmidt MK; Al-Mamgani A; Wildeman MA; Haryana SM; Indrasari SR; Tan IB
    PLoS One; 2016; 11(3):e0151899. PubMed ID: 27030990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy.
    Hendry JH; Bentzen SM; Dale RG; Fowler JF; Wheldon TE; Jones B; Munro AJ; Slevin NJ; Robertson AG
    Clin Oncol (R Coll Radiol); 1996; 8(5):297-307. PubMed ID: 8934049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer.
    Chen M; Jiang GL; Fu XL; Wang LJ; Qian H; Chen GY; Zhao S; Liu TF
    Lung Cancer; 2000 Apr; 28(1):11-9. PubMed ID: 10704704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of interruptions to radiotherapy in head and neck cancer: an audit of the effectiveness of national guidelines.
    James ND; Williams MV; Summers ET; Jones K; Cottier B;
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):599-605. PubMed ID: 18555671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance to radiation therapy of head and neck cancer patients and impact on treatment outcome.
    Ferreira BC; Sá-Couto P; Lopes MC; Khouri L
    Clin Transl Oncol; 2016 Jul; 18(7):677-84. PubMed ID: 26459252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation.
    Bese NS; Hendry J; Jeremic B
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):654-61. PubMed ID: 17467926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Interruptions in Radiation Therapy for Head-and-Neck Cancer: Rates and Causes.
    Giddings A
    J Med Imaging Radiat Sci; 2010 Dec; 41(4):222-229. PubMed ID: 31051883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
    Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical radiobiology of stage T2-T3 bladder cancer.
    Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
    Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awareness and surveillance of radiation treatment schedules reduces head and neck overall treatment time.
    Christiansen RL; Gornitzka J; Andersen P; Nielsen M; Johnsen L; Bertelsen AS; Zukauskaite R; Johansen J; Hansen CR
    Tech Innov Patient Support Radiat Oncol; 2019 Mar; 9():26-30. PubMed ID: 32095592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas.
    Khalil AA; Bentzen SM; Bernier J; Saunders MI; Horiot JC; Van Den Bogaert W; Cummings BJ; Dische S
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):568-75. PubMed ID: 12573743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical methods for compensating for missed treatment days in radiotherapy, with particular reference to head and neck schedules.
    Dale RG; Hendry JH; Jones B; Robertson AG; Deehan C; Sinclair JA
    Clin Oncol (R Coll Radiol); 2002 Oct; 14(5):382-93. PubMed ID: 12555877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors].
    Altmann S; Hoffmanns H
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():30-3. PubMed ID: 10584138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of the timing of a gap in radiotherapy of squamous cell carcinomas of the head and neck.
    Herrmann T; Jakubek A; Trott KR
    Strahlenther Onkol; 1994 Sep; 170(9):545-9. PubMed ID: 7940126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Delays and treatment interruptions: difficulties in administering radiotherapy in an ideal time-period].
    González San Segundo C; Calvo Manuel FA; Santos Miranda JA
    Clin Transl Oncol; 2005 Mar; 7(2):47-54. PubMed ID: 15899208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.